Hancock Jaffe Laboratories Inc (NQ: HJLI )
6.060
USD
+0.170
(+2.89%)
Official Closing Price
Updated: 7:19 PM EDT, Apr 16, 2021
Add to My Watchlist
Press releases about Hancock Jaffe Laboratories Inc
First U.S. Patent Issues on Hancock Jaffe VenoValve
April 07, 2021
From ACCESSWIRE
From ACCESSWIRE
From ACCESSWIRE
First U.S. Patent Allowed on Hancock Jaffe VenoValve
February 24, 2021
From ACCESSWIRE
Hancock Jaffe Completes $41 Million Public Offering
February 11, 2021
From ACCESSWIRE
From ACCESSWIRE
From ACCESSWIRE
Hancock Jaffe Announces Executive Promotions
December 30, 2020
From ACCESSWIRE
From ACCESSWIRE
From ACCESSWIRE
Hancock Jaffe to Provide VenoValve and CoreoGraft Updates at Ladenburg Thalmann R&D Showcase Webinar on December 16, 2020
December 10, 2020
From ACCESSWIRE
From ACCESSWIRE
Thinking about buying stock in Hancock Jaffe, Oramed Pharmaceuticals, Tilray, Hexo Corp, or Arbutus Biopharma?
November 30, 2020
From PR Newswire
Hancock Jaffe Announces Reverse Stock Split
November 27, 2020
From ACCESSWIRE
Hancock Jaffe's VenoValve(R) Results Featured in Journal of Vascular Surgery Venous and Lymphatic Disorders
November 23, 2020
From ACCESSWIRE
Hancock Jaffe Announces Date for VenoValve Pre-IDE Meeting with FDA
November 05, 2020
From ACCESSWIRE
Hancock Jaffe Reports Successful Completion of First CoreoGraft Heart Bypass Surgery
October 28, 2020
From ACCESSWIRE
Hancock Jaffe Submits VenoValve Pre-IDE Filing to FDA
October 27, 2020
From ACCESSWIRE
From ACCESSWIRE
Hancock Jaffe to Begin CoreoGraft First-in-Human Study
October 14, 2020
From ACCESSWIRE
Hancock Jaffe Engages Syntactx for VenoValve U.S. Pivotal Trial
October 08, 2020
From ACCESSWIRE
Hancock Jaffe Laboratories, Inc. Announces Pricing of $5.1 Million Registered Direct Offering Priced at the Market
October 07, 2020
From ACCESSWIRE
Hancock Jaffe Announces Positive Nasdaq Listing Determination
September 21, 2020
From ACCESSWIRE
From ACCESSWIRE
Hancock Jaffe Announces One Year Follow-up Data on Two Additional VenoValve Patients
August 21, 2020
From ACCESSWIRE
From ACCESSWIRE
From ACCESSWIRE
Hancock Jaffe Laboratories Announces Closings of $6.2 Million Offerings Including Full Exercise of Over-Allotment Option
July 21, 2020
From ACCESSWIRE
From ACCESSWIRE
From ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.